News + Filings Transactions Holdings
|
SCANGOS GEORGE A
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/06/2023 | Voyager Therapeutics, Inc. | VYGR | Grant | Stock Option (Right to Buy) | 22k | $12.57 | $276.5k | | 06/06/2023 |
05/09/2023 | Voyager Therapeutics, Inc. | VYGR | Grant | Stock Option (Right to Buy) | 44k | $10.76 | $473.4k | | 05/09/2023 |
03/16/2023 | AGILENT TECHNOLOGIES, INC. | A | Grant | Common Stock | 1.7k | $136.82 | $226.8k | | 03/16/2023 |
02/24/2023 | Vir Biotechnology, Inc. | VIR | Sale | Common Stock | 4.2k | $22.74 | $96.4k | | 02/23/2023 |
02/24/2023 | Vir Biotechnology, Inc. | VIR | Sale | Common Stock | 10.9k | $23.56 | $256.3k | | 02/23/2023 |
02/23/2023 | Vir Biotechnology, Inc. | VIR | Sale | Common Stock | 12.6k | $25.97 | $328.1k | | 02/23/2023 |
02/21/2023 | Vir Biotechnology, Inc. | VIR | Sale | Common Stock | 11.4k | $28.02 | $318.9k | | 02/17/2023 |
02/21/2023 | Vir Biotechnology, Inc. | VIR | Sale | Common Stock | 6.5k | $28.80 | $186.5k | | 02/17/2023 |
02/17/2023 | Vir Biotechnology, Inc. | VIR | Sale | Common Stock | 9.9k | $25.29 | $250.2k | | 02/17/2023 |
01/18/2023 | Vir Biotechnology, Inc. | VIR | Other (disposition) | Common Stock | 64.9k | $0.00 | $0 | See footnote | 02/17/2023 |
01/18/2023 | Vir Biotechnology, Inc. | VIR | Other (acquisition) | Common Stock | 64.9k | $0.00 | $0 | See footnote | 02/17/2023 |
12/21/2022 | Vir Biotechnology, Inc. | VIR | Other (disposition) | Common Stock | 50k | $0.00 | $0 | See footnote | 02/17/2023 |
12/21/2022 | Vir Biotechnology, Inc. | VIR | Other (acquisition) | Common Stock | 50k | $0.00 | $0 | See footnote | 02/17/2023 |
12/21/2022 | Vir Biotechnology, Inc. | VIR | Other (disposition) | Common Stock | 50k | $0.00 | $0 | See footnote | 02/17/2023 |
12/21/2022 | Vir Biotechnology, Inc. | VIR | Other (acquisition) | Common Stock | 50k | $0.00 | $0 | See footnote | 02/17/2023 |
03/17/2022 | AGILENT TECHNOLOGIES, INC. | A | Grant | Common Stock | 1.8k | $136.82 | $244.2k | | 03/17/2022 |
03/10/2022 | Vir Biotechnology, Inc. | VIR | Grant | Common Stock | 111k | $0.00 | $0 | | 03/10/2022 |
03/10/2022 | Vir Biotechnology, Inc. | VIR | Grant | Stock Option (Right to Buy) | 222k | $29.48 | $6.5M | | 03/10/2022 |
02/18/2022 | Vir Biotechnology, Inc. | VIR | Sale | Common Stock | 17.7k | $30.65 | $543.3k | | 02/17/2022 |
02/17/2022 | Vir Biotechnology, Inc. | VIR | Sale | Common Stock | 10k | $31.93 | $320.1k | | 02/17/2022 |
03/18/2021 | AGILENT TECHNOLOGIES, INC. | A | Grant | Common Stock | 1.8k | $121.59 | $224.9k | | 03/18/2021 |
03/18/2021 | AGILENT TECHNOLOGIES, INC. | A | Grant | Common Stock | 986 | $121.59 | $119.9k | | 03/18/2021 |
02/16/2021 | Vir Biotechnology, Inc. | VIR | Grant | Stock Option (Right to Buy) | 222k | $67.38 | $15M | | 02/16/2021 |
02/16/2021 | Vir Biotechnology, Inc. | VIR | Grant | Common Stock | 111k | $0.00 | $0 | | 02/16/2021 |
08/03/2020 | AGILENT TECHNOLOGIES, INC. | A | Grant | Common Stock | 177 | $93.91 | $16.6k | | 08/03/2020 |
05/18/2020 | EXELIXIS, INC. | EXEL | Sale | Common Stock | 75k | $25.96 | $1.9M | | 05/18/2020 |
05/15/2020 | EXELIXIS, INC. | EXEL | Exercise | Option (right to buy) | 30k | $4.58 | $137.4k | | 05/15/2020 |
05/15/2020 | EXELIXIS, INC. | EXEL | Exercise | Option (right to buy) | 21.7k | $5.82 | $126.2k | | 05/15/2020 |
04/24/2020 | EXELIXIS, INC. | EXEL | Sale | Common Stock | 15k | $26.24 | $393.6k | | 04/23/2020 |
04/23/2020 | EXELIXIS, INC. | EXEL | Sale | Common Stock | 44.3k | $25.68 | $1.1M | | 04/23/2020 |
04/23/2020 | EXELIXIS, INC. | EXEL | Sale | Common Stock | 55.7k | $26.23 | $1.5M | | 04/23/2020 |
04/22/2020 | EXELIXIS, INC. | EXEL | Sale | Common Stock | 4.2k | $25.05 | $105.2k | | 04/20/2020 |
04/21/2020 | EXELIXIS, INC. | EXEL | Sale | Common Stock | 5.8k | $25.04 | $145.2k | | 04/20/2020 |
04/20/2020 | EXELIXIS, INC. | EXEL | Sale | Common Stock | 18.5k | $23.39 | $432.7k | | 04/20/2020 |
04/20/2020 | EXELIXIS, INC. | EXEL | Sale | Common Stock | 25.6k | $24.07 | $616.2k | | 04/20/2020 |
|
|